Outcomes of Orbital Atherectomy in Severely Calcified Small (2.5 mm) Coronary Artery Vessels.
We evaluated the outcomes of plaque modification with orbital atherectomy followed by percutaneous coronary intervention (PCI) with small-diameter stents for severely calcified coronary arteries. PCI of severely calcified lesions is technically complex due to difficulties in predilating the lesion, delivering the stent, and achieving optimal stent expansion. PCI of small-diameter vessels is associated with an increased risk of adverse clinical events. In our retrospective multicenter registry of 458 "all comers" with severe coronary artery calcification treated with orbital atherectomy, a total of 38 patients (8.3%) underwent stenting with a 2.5 mm diameter stent (small-vessel group) and 420 patients (91.7%) had a reference vessel diameter >2.5 mm (large-vessel group). The primary endpoint was the 30-day rate of major adverse cardiac and cerebrovascular events, which was the composite of death, myocardial infarction (MI), target-vessel revascularization (TVR), and stroke. The small-vessel and large-vessel groups had similar rates of perforation (0.0% vs 0.7%; P=.80), dissection (2.6% vs 0.7%; P=.20), and no-reflow (0.0% vs 0.7%; P=.80). The primary endpoint was similar in both groups (0.0% vs 1.9%; P=.40), as were the rates of death (0.0% vs 1.4%; P=.40), MI (0.0% vs 1.2%; P=.50), TVR (0.0% vs 0.0%; P>.99), and stroke (0.0% vs 0.2%; P=.90). The small-vessel and large-vessel groups had similar rates of stent thrombosis (0.0% vs 1.0%; P=.70). Orbital atherectomy followed by stenting of small-diameter vessels appears to be feasible and safe. Further studies are needed to determine the ideal revascularization strategy for these patients.